Skip to content

LARIMAR THERAPEUTICS, INC.: filings

Every LARIMAR THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 49 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-04fiscal Q2 202634860001193125-26-331529
10-Q2026-05-14fiscal Q1 202634670001193125-26-224087
10-K2026-03-19fiscal FY 202536720001193125-26-115878
10-Q2025-11-05fiscal Q3 2025361050001193125-25-266969
10-Q2025-08-14fiscal Q2 2025381050000950170-25-108797
10-Q2025-04-30fiscal Q1 202537730000950170-25-061222
10-K2025-03-24fiscal FY 202440790000950170-25-043925
10-Q2024-10-30fiscal Q3 2024371040000950170-24-119100
10-Q2024-08-08fiscal Q2 202437990000950170-24-093733
10-Q2024-05-09fiscal Q1 202436720000950170-24-056965
10-K2024-03-14fiscal FY 202340790000950170-24-031529
10-Q2023-11-14fiscal Q3 2023371040000950170-23-063517
10-Q2023-08-10fiscal Q2 202336980000950170-23-041293
10-Q2023-05-15fiscal Q1 202335690000950170-23-022187
10-K2023-03-14fiscal FY 202240790000950170-23-007855
10-Q2022-11-10fiscal Q3 2022371040000950170-22-024223
10-Q2022-08-11fiscal Q2 202236980000950170-22-016917
10-Q2022-05-12fiscal Q1 202233660000950170-22-009590
10-K2022-03-25fiscal FY 202140790000950170-22-004637
10-Q2021-11-12fiscal Q3 2021381070000950170-21-004331
10-Q2021-08-12fiscal Q2 2021381020001564590-21-043701
10-Q2021-05-10fiscal Q1 202133640001564590-21-026084
10-K2021-03-04fiscal FY 202036700001564590-21-011003
10-Q2020-11-12fiscal Q3 202034870001564590-20-053618
10-Q2020-08-14fiscal Q2 202034830001564590-20-040314
10-Q2020-05-07fiscal Q1 202035690001564590-20-022942
10-K2020-03-05fiscal FY 2019421250001564590-20-008984
10-Q2019-11-06fiscal Q3 201936970001564590-19-041090
10-Q2019-08-08fiscal Q2 201936930001564590-19-030904
10-Q2019-05-09fiscal Q1 201935680001564590-19-018086
10-K2019-03-14fiscal FY 2018401240001564590-19-007863
10-Q2018-11-09fiscal Q3 201833860001564590-18-028944
10-Q2018-08-09fiscal Q2 201832830001193125-18-244422
10-Q2018-05-10fiscal Q1 201828570001193125-18-159281
10-K2018-03-09fiscal FY 2017351090001193125-18-077456
10-Q2017-11-07fiscal Q3 201727740001193125-17-335910
10-Q2017-08-09fiscal Q2 201727740001193125-17-252840
10-Q2017-05-09fiscal Q1 201727560001193125-17-164257
10-K2017-03-10fiscal FY 2016351130001193125-17-078784
10-Q2016-11-09fiscal Q3 201629760001193125-16-764420
10-Q2016-08-05fiscal Q2 201628740001193125-16-672131
10-Q2016-05-10fiscal Q1 201628560001193125-16-585718
10-K2016-03-15fiscal FY 2015321060001193125-16-505173
10-Q2015-11-13fiscal Q3 201528770001193125-15-377065
10-Q2015-08-14fiscal Q2 201528770001193125-15-291736
10-Q2015-05-14fiscal Q1 201528560001193125-15-188267
10-K2015-03-25fiscal FY 2014311020001193125-15-103624
10-Q2014-11-13fiscal Q3 201424640001193125-14-411306
10-Q2014-08-14fiscal Q2 201424640001193125-14-310145

Inspect the source

Entity
LARIMAR THERAPEUTICS, INC. / CIK 0001374690
Captured
2026-09-19T11:17:50.717Z
SEC response SHA-256
08638b3759f4b65e6e121b92d928b796b8584ccbcb8cfc63b68c5bc067fd2552

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001374690.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))